6 467

Cited 5 times in

Another Beneficial Effect of Rituximab on Refractory ANCA-Associated Vasculitis: The Role of Interleukin-17 Suppression?

DC Field Value Language
dc.contributor.author신재일-
dc.date.accessioned2014-12-18T09:24:11Z-
dc.date.available2014-12-18T09:24:11Z-
dc.date.issued2013-
dc.identifier.issn0300-9475-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/88104-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfSCANDINAVIAN JOURNAL OF IMMUNOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAnimals-
dc.subject.MESHAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy*-
dc.subject.MESHAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/immunology-
dc.subject.MESHAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/metabolism-
dc.subject.MESHAntibodies, Monoclonal, Murine-Derived/therapeutic use*-
dc.subject.MESHHumans-
dc.subject.MESHImmunologic Factors/therapeutic use-
dc.subject.MESHInterleukin-17/immunology*-
dc.subject.MESHInterleukin-17/metabolism-
dc.subject.MESHMice-
dc.subject.MESHRituximab-
dc.subject.MESHTh17 Cells/drug effects-
dc.subject.MESHTh17 Cells/immunology-
dc.subject.MESHTh17 Cells/metabolism-
dc.titleAnother Beneficial Effect of Rituximab on Refractory ANCA-Associated Vasculitis: The Role of Interleukin-17 Suppression?-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pediatrics (소아과학)-
dc.contributor.googleauthorS. J. Park-
dc.contributor.googleauthorJ. I. Shin-
dc.identifier.doi10.1111/sji.12025-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02142-
dc.relation.journalcodeJ02633-
dc.identifier.eissn1365-3083-
dc.identifier.pmid23298391-
dc.identifier.urlhttp://onlinelibrary.wiley.com/doi/10.1111/sji.12025/abstract-
dc.subject.keywordAnimals-
dc.subject.keywordAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy*-
dc.subject.keywordAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/immunology-
dc.subject.keywordAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/metabolism-
dc.subject.keywordAntibodies, Monoclonal, Murine-Derived/therapeutic use*-
dc.subject.keywordHumans-
dc.subject.keywordImmunologic Factors/therapeutic use-
dc.subject.keywordInterleukin-17/immunology*-
dc.subject.keywordInterleukin-17/metabolism-
dc.subject.keywordMice-
dc.subject.keywordRituximab-
dc.subject.keywordTh17 Cells/drug effects-
dc.subject.keywordTh17 Cells/immunology-
dc.subject.keywordTh17 Cells/metabolism-
dc.contributor.alternativeNameShin, Jae Il-
dc.contributor.affiliatedAuthorShin, Jae Il-
dc.rights.accessRightsnot free-
dc.citation.volume77-
dc.citation.number3-
dc.citation.startPage221-
dc.identifier.bibliographicCitationSCANDINAVIAN JOURNAL OF IMMUNOLOGY, Vol.77(3) : 221, 2013-
dc.identifier.rimsid33057-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.